000 01703 a2200469 4500
005 20250513040109.0
264 0 _c19930318
008 199303s 0 0 eng d
022 _a0085-2538
024 7 _a10.1038/ki.1993.24
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaragoudakis, M E
245 0 0 _aBasement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties.
_h[electronic resource]
260 _bKidney international
_cJan 1993
300 _a147-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
_xanalogs & derivatives
650 0 4 _aAllantois
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBasement Membrane
_xdrug effects
650 0 4 _aBridged-Ring Compounds
_xpharmacology
650 0 4 _aCarcinoma 256, Walker
_xblood supply
650 0 4 _aChick Embryo
650 0 4 _aChorion
_xdrug effects
650 0 4 _aCollagen
_xbiosynthesis
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aNeovascularization, Pathologic
_xmetabolism
650 0 4 _aNorbornanes
650 0 4 _aRats
650 0 4 _aThiocarbamates
650 0 4 _aThiones
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aMissirlis, E
700 1 _aKarakiulakis, G D
700 1 _aSarmonica, M
700 1 _aBastakis, M
700 1 _aTsopanoglou, N
773 0 _tKidney international
_gvol. 43
_gno. 1
_gp. 147-50
856 4 0 _uhttps://doi.org/10.1038/ki.1993.24
_zAvailable from publisher's website
999 _c7678880
_d7678880